THE Zambia Medicines and Medical Supplies Agency (ZAMMSA) says it has received the second batch of the Long-Acting Injectable Cabotegravir (CAB-LA) for HIV prevention from the United States government. In a statement, Wednesday, ZAMMSA Senior Manager – Corporate Communications Bradley Chingobe disclosed that the new consignment, 20,250 vials, was received yesterday and would be distributed to selected health facilities across the country. “Zambia has received the second batch of the Long-Acting Injectable Cabotegravir (CAB-LA) for HIV prevention from the United States government through the USAID Global Health Supply Chain-Procurement & Supply Management (GHSC-PSM). In February 2024, Zambia became the first African country to have access to Injectable PrEP after receiving 15,000 vials of CAB-LA and was launched by Health Minister,...